Conexio Genomics

Follow
Follow Organisations, People and Lists Upgrade your subscription to use this feature.
A life sciences company located in Fremantle that supplies a wide range of sequencing and mutation detection products and services to the global market. It was founded in 2002 by Dr David Sayer and Dr Damian Goodridge and has established itself as a leader in its field with over 200 laboratories using its technology. In January 2016 the business was acquired by American company Illumina, which now owns all Conexio shares. The acquisition will still use the Conexio brand name with some of its products.

Contact Details

PO BOX 1294, FREMANTLE WA 6959
(08) 9336 4212

Article Timeline

Company Activity

Pierre Quesnel
NEW ROLE: Pierre Quesnel, Research Scientist29 Jun 2020

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options